SUPN

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Supernus Pharmaceuticals Inc

NASDAQ | SUPN

49.76

USD

+$0.00

(

+0.00%

)

At Close (As of Oct 16, 2025)

$2.76B

Market Cap

42.84

P/E Ratio

1.15

EPS

$51.78

52 Week High

$29.16

52 Week Low

HEALTHCARE

Sector

SUPN Chart

Recent Chart
Price Action

SUPN Technicals

Tags:

SUPN Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $584M
Total Revenue $662M
Cost Of Revenue $78M
Costof Goods And Services Sold $78M
Operating Income $82M
Selling General And Administrative $247M
Research And Development $109M
Operating Expenses $502M
Investment Income Net -
Net Interest Income $16M
Interest Income $16M
Interest Expense $0
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $80M
Income Before Tax $98M
Income Tax Expense $24M
Interest And Debt Expense -
Net Income From Continuing Operations $74M
Comprehensive Income Net Of Tax -
Ebit $98M
Ebitda $178M
Net Income $74M

Revenue & Profitability

Earnings Performance

SUPN Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $1.4B
Total Current Assets $686M
Cash And Cash Equivalents At Carrying Value $69M
Cash And Short Term Investments $69M
Inventory $54M
Current Net Receivables $142M
Total Non Current Assets $682M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $522M
Intangible Assets Excluding Goodwill $522M
Goodwill $117M
Investments -
Long Term Investments $0
Short Term Investments $384M
Other Current Assets $36M
Other Non Current Assets -
Total Liabilities $332M
Total Current Liabilities $292M
Current Accounts Payable $4.6M
Deferred Revenue -
Current Debt -
Short Term Debt $6.9M
Total Non Current Liabilities $40M
Capital Lease Obligations $34M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $34M
Other Current Liabilities $281M
Other Non Current Liabilities $7.6M
Total Shareholder Equity $1B
Treasury Stock -
Retained Earnings $556M
Common Stock $56K
Common Stock Shares Outstanding $56M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow $172M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $80M
Capital Expenditures $725K
Change In Receivables -
Change In Inventory $16M
Profit Loss -
Cashflow From Investment -$190M
Cashflow From Financing $12M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income $74M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $584M
Total Revenue $662M
Cost Of Revenue $78M
Costof Goods And Services Sold $78M
Operating Income $82M
Selling General And Administrative $247M
Research And Development $109M
Operating Expenses $502M
Investment Income Net -
Net Interest Income $16M
Interest Income $16M
Interest Expense $0
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $80M
Income Before Tax $98M
Income Tax Expense $24M
Interest And Debt Expense -
Net Income From Continuing Operations $74M
Comprehensive Income Net Of Tax -
Ebit $98M
Ebitda $178M
Net Income $74M

SUPN News

SUPN Profile

Supernus Pharmaceuticals Inc Profile

Sector: HEALTHCARE

Industry: DRUG MANUFACTURERS - SPECIALTY & GENERIC

Supernus Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of innovative therapies for central nervous system disorders, particularly in the United States. Based in Rockville, Maryland, Supernus specializes in addressing unmet medical needs in epilepsy and migraine, supported by a promising pipeline aimed at improving patient outcomes. With a commitment to enhancing quality of life for affected individuals, the company operates in a rapidly expanding market, presenting substantial growth opportunities for institutional investors.

VHAI
-20.00%
$0.00
VIVK
-1.72%
$0.28
YYAI
-10.71%
$0.12
BURU
+1.07%
$0.34
EPWK
+26.46%
$0.09
NVDA
-0.11%
$179.83
IVF
+85.67%
$1.40
BITF
-18.39%
$5.28
RXRX
-7.21%
$6.29
CGBS
-39.47%
$0.03
COOT
+173.57%
$2.64
PLUG
-8.70%
$3.51
ADAP
+6.57%
$0.19
BYND
-22.39%
$0.52
YDKG
-54.14%
$0.08
NVTS
+3.10%
$15.63
RGTI
-14.85%
$47.97
DNN
-2.83%
$3.08
LAES
-2.09%
$7.49
NIO
-1.09%
$6.74
MIRA
+36.36%
$1.80
SCNX
-17.63%
$0.58
F
-0.27%
$11.72
BBD
+1.71%
$3.25
WHWK
+24.28%
$2.61
ACHR
-8.90%
$11.87
TLRY
-8.33%
$1.54
HPE
-10.06%
$22.52
KVUE
-13.43%
$14.07
TSLA
-1.47%
$428.75
ONDS
-13.77%
$8.19
IONZ
+18.46%
$3.41
DFLI
-32.48%
$1.33
AXDX
-61.36%
$0.03
INTC
-1.10%
$36.74
ETHD
+6.47%
$3.78
RIG
-2.56%
$3.22
CAN
-14.28%
$1.68
AAL
-4.88%
$11.89
AMD
-1.33%
$235.40
SOFI
-6.13%
$26.31
GDXD
-7.91%
$0.61
MARA
-11.62%
$20.18
BTBT
-9.11%
$3.69
CLF
-3.39%
$13.47
GNPX
-43.39%
$0.47
BTG
+3.96%
$5.89
FEMY
+33.89%
$0.73
VSEE
-13.85%
$0.51
QS
-13.41%
$15.45
RR
-7.95%
$5.67
GPUS
-6.14%
$0.36
LGCB
+19.39%
$1.97
ABAT
-21.00%
$8.94
NAK
-4.34%
$2.64
QBTS
-10.47%
$40.08
SNAP
-1.83%
$7.76
CIFR
-10.98%
$18.72
CRML
-14.52%
$19.42
QSI
-3.23%
$2.54
RF
-5.98%
$23.26
RGTZ
+30.51%
$11.35
PFE
-0.65%
$24.23
MASK
+17.35%
$0.57
UUUU
-12.80%
$21.79
QUBT
-12.12%
$18.65
KEY
-5.35%
$16.78
HBAN
-5.00%
$15.39
IREN
-8.94%
$61.89
PLTR
-0.83%
$178.12
SOUN
-2.99%
$20.76
WTO
-88.87%
$0.13
CLSK
-13.92%
$19.97
SMR
-10.87%
$47.62
T
+0.46%
$26.19
RMBL
+60.50%
$3.21
AAPL
-0.75%
$247.45
GRAB
-3.54%
$5.71
ASST
-11.57%
$0.84
ADD
-25.47%
$0.05
WOK
+3.29%
$0.05
SOND
+79.34%
$1.65
AUUD
+0.97%
$2.06
NOK
+0.53%
$5.68
WULF
-9.53%
$13.99
BAC
-4.03%
$50.17
MU
+4.60%
$200.77
JOBY
-8.66%
$16.07
IONQ
-9.33%
$65.65
APLD
-1.69%
$37.11
NEHC
+9.12%
$3.35
SRM
+53.27%
$10.30
SATL
-29.71%
$2.91
BMNR
-4.90%
$51.16
TOVX
-47.86%
$0.43
KDLY
+1.29%
$0.79
SLNH
-1.39%
$4.23
JBLU
-4.94%
$4.70
AMC
-2.12%
$2.76
AMZN
-0.81%
$213.82
VHAI
-20.00%
$0.00
VIVK
-1.72%
$0.28
YYAI
-10.71%
$0.12
BURU
+1.07%
$0.34
EPWK
+26.46%
$0.09
NVDA
-0.11%
$179.83
IVF
+85.67%
$1.40
BITF
-18.39%
$5.28
RXRX
-7.21%
$6.29
CGBS
-39.47%
$0.03
COOT
+173.57%
$2.64
PLUG
-8.70%
$3.51
ADAP
+6.57%
$0.19
BYND
-22.39%
$0.52
YDKG
-54.14%
$0.08
NVTS
+3.10%
$15.63
RGTI
-14.85%
$47.97
DNN
-2.83%
$3.08
LAES
-2.09%
$7.49
NIO
-1.09%
$6.74
MIRA
+36.36%
$1.80
SCNX
-17.63%
$0.58
F
-0.27%
$11.72
BBD
+1.71%
$3.25
WHWK
+24.28%
$2.61
ACHR
-8.90%
$11.87
TLRY
-8.33%
$1.54
HPE
-10.06%
$22.52
KVUE
-13.43%
$14.07
TSLA
-1.47%
$428.75
ONDS
-13.77%
$8.19
IONZ
+18.46%
$3.41
DFLI
-32.48%
$1.33
AXDX
-61.36%
$0.03
INTC
-1.10%
$36.74
ETHD
+6.47%
$3.78
RIG
-2.56%
$3.22
CAN
-14.28%
$1.68
AAL
-4.88%
$11.89
AMD
-1.33%
$235.40
SOFI
-6.13%
$26.31
GDXD
-7.91%
$0.61
MARA
-11.62%
$20.18
BTBT
-9.11%
$3.69
CLF
-3.39%
$13.47
GNPX
-43.39%
$0.47
BTG
+3.96%
$5.89
FEMY
+33.89%
$0.73
VSEE
-13.85%
$0.51
QS
-13.41%
$15.45
RR
-7.95%
$5.67
GPUS
-6.14%
$0.36
LGCB
+19.39%
$1.97
ABAT
-21.00%
$8.94
NAK
-4.34%
$2.64
QBTS
-10.47%
$40.08
SNAP
-1.83%
$7.76
CIFR
-10.98%
$18.72
CRML
-14.52%
$19.42
QSI
-3.23%
$2.54
RF
-5.98%
$23.26
RGTZ
+30.51%
$11.35
PFE
-0.65%
$24.23
MASK
+17.35%
$0.57
UUUU
-12.80%
$21.79
QUBT
-12.12%
$18.65
KEY
-5.35%
$16.78
HBAN
-5.00%
$15.39
IREN
-8.94%
$61.89
PLTR
-0.83%
$178.12
SOUN
-2.99%
$20.76
WTO
-88.87%
$0.13
CLSK
-13.92%
$19.97
SMR
-10.87%
$47.62
T
+0.46%
$26.19
RMBL
+60.50%
$3.21
AAPL
-0.75%
$247.45
GRAB
-3.54%
$5.71
ASST
-11.57%
$0.84
ADD
-25.47%
$0.05
WOK
+3.29%
$0.05
SOND
+79.34%
$1.65
AUUD
+0.97%
$2.06
NOK
+0.53%
$5.68
WULF
-9.53%
$13.99
BAC
-4.03%
$50.17
MU
+4.60%
$200.77
JOBY
-8.66%
$16.07
IONQ
-9.33%
$65.65
APLD
-1.69%
$37.11
NEHC
+9.12%
$3.35
SRM
+53.27%
$10.30
SATL
-29.71%
$2.91
BMNR
-4.90%
$51.16
TOVX
-47.86%
$0.43
KDLY
+1.29%
$0.79
SLNH
-1.39%
$4.23
JBLU
-4.94%
$4.70
AMC
-2.12%
$2.76
AMZN
-0.81%
$213.82
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.